Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

RWE

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

03/27/2024 04:47 PM ET

Gamida Cell Ltd. AVTE date announcement

Aerovate Therapeutics plans to announce top-line results for their Phase 2/3 trial of AV-101 - (IMPAHCT) on June 30, 2024. As of now, the drug has a 29.6% chance of moving on.

Aerovate Therapeutics rocketed [...]

Read More
03/27/2024 04:47 PM ET

Longeveron AVIR date announcement

Now that the Phase 3 trial of Bemnifosbuvir (AT-527) - (SUNRISE-3) is completed, Atea Pharmaceuticals will announce their top-line results on March 31, 2024. The community is currently bullish on the prospects of progression, as [...]

Read More
03/27/2024 04:47 PM ET

Moderna MRNA results announcement

Moderna provided an update to their Phase 3 trial for Trivalent (mRNA-1403). The results were summarized as follows:

"Phase 3 trial planned."

The market liked what it heard. Moderna shot up $3.18 (+2.96%) to $110.59 on

Read More
03/27/2024 04:47 PM ET

Argenx SE ARGX date announcement

After specifying an announcement date for Efgartigimod - (RHO) trial results, Argenx SE now has 11 catalyst announcements planned. Argenx SE plans to announce top-line results for their Phase 2 trial on June 30, 2024. [...]

Read More

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Go to Top